ATE82262T1 - Piperidin-derivate. - Google Patents

Piperidin-derivate.

Info

Publication number
ATE82262T1
ATE82262T1 AT89306881T AT89306881T ATE82262T1 AT E82262 T1 ATE82262 T1 AT E82262T1 AT 89306881 T AT89306881 T AT 89306881T AT 89306881 T AT89306881 T AT 89306881T AT E82262 T1 ATE82262 T1 AT E82262T1
Authority
AT
Austria
Prior art keywords
chem
formula
group
piperidine derivatives
substituents
Prior art date
Application number
AT89306881T
Other languages
English (en)
Inventor
David Dr Alker
Peter Edward Dr Cross
Robert Michael Dr Wallis
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE82262T1 publication Critical patent/ATE82262T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT89306881T 1988-07-08 1989-07-06 Piperidin-derivate. ATE82262T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888816365A GB8816365D0 (en) 1988-07-08 1988-07-08 Therapeutic agents
EP89306881A EP0350309B1 (de) 1988-07-08 1989-07-06 Piperidin-Derivate

Publications (1)

Publication Number Publication Date
ATE82262T1 true ATE82262T1 (de) 1992-11-15

Family

ID=10640168

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89306881T ATE82262T1 (de) 1988-07-08 1989-07-06 Piperidin-derivate.

Country Status (28)

Country Link
US (1) US5089505A (de)
EP (1) EP0350309B1 (de)
JP (2) JPH0739388B2 (de)
KR (1) KR930002728B1 (de)
CN (1) CN1022914C (de)
AT (1) ATE82262T1 (de)
AU (1) AU602453B2 (de)
CA (1) CA1336833C (de)
DD (1) DD284011A5 (de)
DE (1) DE68903437T2 (de)
DK (1) DK337589A (de)
EG (1) EG18853A (de)
ES (1) ES2052917T3 (de)
FI (1) FI94241C (de)
GB (1) GB8816365D0 (de)
GR (1) GR3006595T3 (de)
HU (1) HUT50771A (de)
IE (1) IE63438B1 (de)
IL (1) IL90792A0 (de)
MX (1) MX16728A (de)
MY (1) MY106976A (de)
NO (1) NO892828L (de)
NZ (1) NZ229865A (de)
PL (2) PL162318B1 (de)
PT (1) PT91081B (de)
RU (2) RU1838307C (de)
YU (1) YU135389A (de)
ZA (1) ZA895175B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231104A (en) * 1988-07-08 1993-07-27 Pfizer Inc. 1-arylethyl-3-substituted piperidines
GB9000301D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Piperidine & pyrrolidine derivatives
GB9208230D0 (en) * 1992-04-14 1992-05-27 Pfizer Ltd Treatment of delayed gastric emptying
US5340826A (en) * 1993-02-04 1994-08-23 Pfizer Inc. Pharmaceutical agents for treatment of urinary incontinence
GB9400600D0 (en) * 1994-01-14 1994-03-09 Pfizer Ltd Treatment of motion seckness
US6331541B1 (en) 1998-12-18 2001-12-18 Soo S. Ko N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
TR200101859T2 (tr) * 1998-12-18 2001-12-21 Dupont Pharmaceuticals Company Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
AU3126700A (en) 1998-12-18 2000-07-03 Du Pont Pharmaceuticals Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
CA2346933A1 (en) * 1998-12-18 2000-06-22 Dupont Pharmaceuticals Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6525069B1 (en) 1998-12-18 2003-02-25 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6897234B2 (en) 1999-12-17 2005-05-24 Bristol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
EP1296978A2 (de) 2000-06-30 2003-04-02 Bristol-Myers Squibb Company N-ureidoheterocycloaklylpiperidine als modulatoren der chemokinrezeptoraktivität
CA2422055A1 (en) * 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
US6508872B2 (en) * 2001-02-26 2003-01-21 Hewlett-Packard Company Lightfast additive molecule for inkjet ink
WO2008144602A1 (en) * 2007-05-18 2008-11-27 Auspex Pharmaceuticals, Inc. Deuterated zamifenacin derivatives
EP2578569B1 (de) * 2010-05-27 2015-10-28 ASKA Pharmaceutical Co., Ltd. Heterozyklische ringverbindung und h1-rezeptor-antagonist
CN107129453B (zh) * 2016-02-26 2019-10-11 中国科学院大连化学物理研究所 化合物、毒蕈碱m受体拮抗剂、组合物及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA541598A (en) * 1957-05-28 Levy Joseph N-substituted-4-benzhydryl etherpiperidines and method for obtaining the same
GB688345A (en) * 1951-02-19 1953-03-04 Greenwood And Hughes Ltd Improvements in sanitary liquid traps
US2745837A (en) * 1954-01-21 1956-05-15 Schering Corp Benzhydryl ethers of alkyl piperidinols
GB780027A (en) * 1955-01-20 1957-07-31 Schering Corp 3-piperidyl ethers and thioethers
US2974146A (en) * 1956-02-24 1961-03-07 Lakeside Lab Inc 3-piperidyl benzhydryl ethers
NL237664A (de) * 1959-04-01

Also Published As

Publication number Publication date
NZ229865A (en) 1991-01-29
FI893326A0 (fi) 1989-07-07
KR900001683A (ko) 1990-02-27
MY106976A (en) 1995-08-30
GB8816365D0 (en) 1988-08-10
FI94241B (fi) 1995-04-28
JPH0739388B2 (ja) 1995-05-01
FI893326A (fi) 1990-01-09
DE68903437T2 (de) 1993-03-25
IL90792A0 (en) 1990-01-18
ES2052917T3 (es) 1994-07-16
IE892202L (en) 1990-01-08
GR3006595T3 (de) 1993-06-30
AU3797189A (en) 1990-02-15
IE63438B1 (en) 1995-04-19
EP0350309B1 (de) 1992-11-11
HUT50771A (en) 1990-03-28
PL161887B1 (pl) 1993-08-31
CN1039415A (zh) 1990-02-07
PT91081A (pt) 1990-02-08
NO892828D0 (no) 1989-07-07
JPH0276851A (ja) 1990-03-16
MX16728A (es) 1993-08-01
CA1336833C (en) 1995-08-29
ZA895175B (en) 1991-02-27
KR930002728B1 (ko) 1993-04-09
CN1022914C (zh) 1993-12-01
JPH07157469A (ja) 1995-06-20
DE68903437D1 (de) 1992-12-17
PT91081B (pt) 1995-01-31
RU1836364C (ru) 1993-08-23
PL162318B1 (pl) 1993-09-30
EG18853A (en) 1994-12-30
NO892828L (no) 1990-01-09
DK337589D0 (da) 1989-07-07
US5089505A (en) 1992-02-18
DK337589A (da) 1990-01-09
FI94241C (fi) 1995-08-10
RU1838307C (ru) 1993-08-30
DD284011A5 (de) 1990-10-31
AU602453B2 (en) 1990-10-11
YU135389A (en) 1991-06-30
EP0350309A1 (de) 1990-01-10

Similar Documents

Publication Publication Date Title
DE68903437T2 (de) Piperidin-derivate.
AU613805B2 (en) Pyrimidinedione derivative compounds, method of producing the same and antiarrythmic agents containing the same
DK0632036T3 (da) Amidderivater med antipypercholesteræmisk aktivitet, deres fremstilling og deres terapeutiske anvendelser
DK0651999T3 (da) Fremgangsmåder til inhibering af livmoderfibrose
FI944822A0 (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
DK0518558T3 (da) 1-methylcarbapenemderivater, deres fremstilling og deres anvendelse som antibiotika
HK1005591A1 (en) D'aryl-3 oxazolidinone derivatives method of preparation and therapeutic application
IE890177L (en) Piperidinyl derivatives
ATE53570T1 (de) Aminoalkylnaphthalen-derivate mit pharmakologischer wirkung.
FI955680A (fi) Psoraleenijohdannaiset, niiden valmistus ja käyttö
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee